Want to see CANN full AI Analyst Report?
CANN Stock Chart & Stats
$0.04
<$0.01(8.79%)
At close: 4:00 PM EST
$0.04
<$0.01(8.79%)
Day’s Range― - ―
52-Week Range<$0.01 - $0.06
Previous CloseN/A
Volume18.50K
Average Volume (3M)152.58K
Market Cap
$2.65M
Enterprise Value$23.31M
Total Cash (Recent Filing)$214.33K
Total Debt (Recent Filing)$17.31M
Price to Earnings (P/E)―
Beta0.03
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding110,934,220
10 Day Avg. Volume152,002
30 Day Avg. Volume152,580
Financial Highlights & Ratios
PEG Ratio0.06
Price to Book (P/B)-0.99
Price to Sales (P/S)0.33
P/FCF Ratio-2.78
Enterprise Value/Market Cap8.79
Enterprise Value/Revenue1.71
Enterprise Value/Gross Profit4.01
Enterprise Value/Ebitda27.44
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Operating Profitability ImprovementEBIT turning positive in 2025 signals the core business may now cover operating costs, reflecting improved unit economics and fixed-cost absorption. This structural shift supports longer-term operating leverage, reducing break-even risk and improving the odds of sustained profitability if revenue stabilizes.
Gross Margin ResilienceA solid gross profit margin indicates underlying product/service economics are intact and the company retains pricing or cost advantages. Durable gross margins provide room to invest in SG&A or R&D while protecting operating margins, supporting margin sustainability across a 2–6 month horizon if cost structure is maintained.
Improving Cash Flow TrendNarrowing free cash flow losses shows progress toward cash generation and better working capital or margin management. While still negative, the trend reduces near-term external funding reliance, improves liquidity outlook, and if sustained can materially lower refinancing risk over several quarters.
Bears Say
Stressed Balance Sheet (negative Equity)Negative equity and high leverage materially weaken financial flexibility and elevate refinancing and covenant risks. A capital structure where debt approximates assets constrains the ability to raise secured funding, increases cost of capital, and can force dilutive or costly financing solutions over the medium term.
Contracting RevenueA multi-year revenue decline undermines scale benefits and makes it harder to sustain recent operating gains. Contracting top line pressures margins long-term, limits reinvestment capacity, and raises the risk that recent EBIT improvement is from cost cuts rather than durable demand recovery.
Persistent Net Losses And Cash BurnOngoing net losses and negative operating cash flow mean continued reliance on external capital or asset sales. This persistent cash burn risks dilution or expensive refinancing, and without sustained cash generation the company may struggle to fund growth or settle obligations over a 2–6 month horizon.
General Cannabis News
CANN FAQ
What was General Cannabis Corp’s price range in the past 12 months?
General Cannabis Corp lowest stock price was <$0.01 and its highest was $0.06 in the past 12 months.
What is General Cannabis Corp’s market cap?
General Cannabis Corp’s market cap is $2.65M.
When is General Cannabis Corp’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were General Cannabis Corp’s earnings last quarter?
Currently, no data Available
Is General Cannabis Corp overvalued?
According to Wall Street analysts General Cannabis Corp’s price is currently Overvalued.
Does General Cannabis Corp pay dividends?
General Cannabis Corp does not currently pay dividends.
What is General Cannabis Corp’s EPS estimate?
General Cannabis Corp’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does General Cannabis Corp have?
General Cannabis Corp has 110,934,220 shares outstanding.
What happened to General Cannabis Corp’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of General Cannabis Corp?
Currently, no hedge funds are holding shares in CANN
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
General Cannabis Corp
Denver, Colorado-based Trees Corporation, founded in 2013, specializes in delivering products and services to both the regulated cannabis sector and general consumers throughout the United States. Its business activities are organized into distinct retail and cultivation divisions. The company's facilities include a 17,000 square foot light-deprivation greenhouse for cultivation, a cannabis dispensary located in Englewood, Colorado, and two additional retail outlets in Portland, Oregon. Formerly known as General Cannabis Corp., the company rebranded to Trees Corporation in June 2022.
Technical Analysis
cbdMD
―
Aquestive Therapeutics
―
IM Cannabis Corp
―
―
Incannex Healthcare Limited Sponsored ADR
―
Ownership Overview
―
Insiders
―
Mutual Funds
<0.01% Other Institutional Investors
100.00% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---